Vol. 1 No. 7: Chronic Lymphocytic Leukemia: Achievements and Controversies

Articles

• Chronic lymphocytic leukemia: an enigma for both the clinician and the immunologist

  Cristina Scielzo, Michela Frenquelli, Marta Muzio, Maria T.S. Bertilaccio, Antonis Dagklis, Federico Caligaris-Cappio, Paolo Ghia

  https://doi.org/10.4081/hmr.v1i7.626

  Published: June 16, 2009

  354

  PDF: 387

  • PDF

• Moving from clinical to biological staging for the management of chronic lymphocytic leukemia

  Marco Montillo, Alessandra Tedeschi, Sara Miqueleiz, Francesca Ricci, Eleonora Vismara, Enrica Morra

  https://doi.org/10.4081/hmr.v1i7.627

  Published: June 16, 2009

  263

  PDF: 218

  • PDF

• First-line therapy of chronic lymphocytic leukemia: when and how to treat

  Ester M. Orlandi

  https://doi.org/10.4081/hmr.v1i7.628

  Published: June 16, 2009

  188

  PDF: 248

  • PDF

• The role of monoclonal antibodies in the therapeutic strategy of chronic lymphocytic leukemia

  Agostino Cortelezzi

  https://doi.org/10.4081/hmr.v1i7.629

  Published: June 16, 2009

  172

  PDF: 285

  • PDF

• Second line treatment for relapsed chronic lymphocytic leukemia

  Giuseppe Rossi

  https://doi.org/10.4081/hmr.v1i7.630

  Published: June 16, 2009

  185

  PDF: 1354

  • PDF

• Refractory chronic lymphocytic leukemia

  Giovanni Martinelli

  https://doi.org/10.4081/hmr.v1i7.631

  Published: June 16, 2009

  212

  PDF: 421

  • PDF

• Management of complications: infections, autoimmunity, cytopenias

  Fausto Rossini

  https://doi.org/10.4081/hmr.v1i7.632

  Published: June 16, 2009

  191

  PDF: 441

  • PDF